Xenical (orlistat) may help improve blood sugar control in overweight and obese type 2 diabetic patients whose oral anti-diabetic medication is failing them, according to new research.
Dr. Paul Valensi with L’Hôpital Jean Verdier, University Paris Nord, France, and colleagues presented the results of their study today (September 2) during the European Association for the Study of Diabetes (EASD), in Budapest, Hungary.
Orlistat blocks the action of lipases, inhibiting the absorption of dietary fats. Thus, the drug may aid weight loss and improve the blood glucose profile of overweight and obese patients with type 2 diabetes.
תגובות רוצה להצטרף לדיון?
יש להתחבר כדי להגיב.
התחבראין תגובות עדיין. היה הראשון להגיב!